ARID1A and breast carcinoma: Although their link with ER biology is better understood in the case of ARID1A-BAF and perhaps less established in the case of NuRD and Polycomb, these examples nonetheless illustrate advances made in our understanding and novel avenues being explored of how repressive complexes can contribute to enhancer functionality in HR+ breast cancer.